亚太肺功能测试市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太肺功能测试市场 – 行业趋势及 2031 年预测

  • Medical Devices
  • Published Report
  • Sep 2024
  • Asia-Pacific
  • 350 页面
  • 桌子數: 317
  • 图号: 34

Asia Pacific Pulmonary Function Testing Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 721.36 Million
Diagram Market Size (Forecast Year)
USD 1,301.52 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>亚太肺功能测试市场,按类型(硬件、服务和软件)、患者类型(儿科、成人和老年人)、应用(阻塞性肺病和限制性肺病)、最终用户(医院、专科诊所、诊断实验室、家庭护理环境等)划分 - 行业趋势和预测到 2031 年。

亚太肺功能测试市场

亚太肺功能测试市场分析与洞察

肺功能测试市场的发展受到呼吸系统疾病患病率不断上升、技术进步和个性化医疗需求不断增长的推动。市场的主要趋势包括即时诊断肺功能测试设备的采用率不断提高、对无线和便携式肺功能测试设备的需求不断增长以及对个性化医疗和精准医疗的关注度不断提高。然而,市场也面临着诸多挑战,例如某些地区肺功能测试设备的可及性有限、肺功能测试设备和耗材成本高、肺功能测试解释和分析复杂以及医疗服务提供者和患者对肺功能测试的认识有限。

Data Bridge Market Research 分析称,亚太肺功能测试市场预计将从 2023 年的 7.2136 亿美元增至 2031 年的 13.0152 亿美元,在 2024 年至 2031 年的预测期内,复合年增长率为 7.7%。

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022(可定制为 2016 – 2021)

定量单位

收入(百万美元)

涵盖的领域

类型(硬件、服务和软件)、患者类型(儿科、成人和老年人)、应用(阻塞性肺病和限制性肺病)、最终用户(医院、专科诊所、诊断实验室、家庭护理环境等)

覆盖国家

中国、印度、韩国、日本、泰国、澳大利亚、新加坡、印度尼西亚、台湾、新西兰、越南、马来西亚、菲律宾以及亚太地区其他地区

涵盖的市场参与者

VYAIRE MEDICAL, INC.、Teleflex Incorporated、CAIRE, Inc.、COSMED srl、Schiller AG、Ganshorn Medizin Electronic GmbH、KoKo PFT、ECO MEDICS、Clarity Medical、Data Sciences International、JK Medical System Pvt. Ltd、Scireq、MEDLINE、Recorders and Medicare Systems、VITALOGRAPH、CHEST MI, Inc.、CONTEC MEDICAL SYSTEMS CO., LTD 和 FUKUDA SANGYO CO., LTD. 等

市场定义

肺功能测试 (PFT) 是对肺功能的全面评估,用于诊断和监测呼吸系统疾病,例如慢性阻塞性肺病 (COPD)、哮喘和慢性支气管炎。PFT 的市场定义包括一系列测试,包括用力肺活量 (FVC)、用力呼气量 (FEV1)、FEV1/FVC 比率、最大自主通气量 (MVV) 和弥散能力 (DLCO)。PFT 通常使用肺量计进行,肺量计是一种测量患者吸入和呼出的空气量和流量的设备。

亚太肺功能测试市场动态

本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容:      

驱动程序

  • 呼吸系统疾病患病率不断上升

呼吸系统疾病的日益流行是全球肺功能测试市场的重要推动力。由于人口老龄化、环境污染物和生活方式改变等因素,慢性阻塞性肺病 (COPD) 和哮喘等疾病变得越来越普遍。随着这些疾病的流行,对准确可靠的诊断工具的需求也随之增加,以管理和监测这些疾病。肺功能测试对于诊断呼吸系统疾病、评估其严重程度和跟踪疾病进展至关重要。随着医疗保健提供者和患者寻求先进的 PFT 技术来改善呼吸系统健康结果并提供有效的管理策略,对定期和精确测试的需求不断增加,推动了市场的发展。

  • 早期发现呼吸系统疾病

早期发现的呼吸系统疾病的增多是全球肺功能测试 (PFT) 市场的主要驱动力。哮喘、慢性阻塞性肺病 (COPD) 和囊性纤维化等呼吸系统疾病的激增推动了对肺功能测试的需求。肺功能测试在早期发现和有效管理呼吸系统疾病方面发挥着至关重要的作用,从而通过及时干预和治疗改善患者的治疗效果和生活质量。

机会

  • 技术飞速进步

创新型肺功能测试设备(尤其是集成人工智能的肺功能测试设备)的开发提高了诊断的准确性和效率,为肺部疾病的诊断提供了更可靠的结果。综合测试系统正变得越来越用户友好和便携,使其能够被更广泛的医疗机构使用。与人工智能和远程医疗等数字医疗技术的结合,可以实现高级诊断准确性和预测分析,以及通过连接的肺功能测试设备进行远程监控,从而扩大这些工具的覆盖范围和影响力。先进的传感器技术(包括高灵敏度和可穿戴传感器)可提供持续监控和实时数据收集,从而实现更精确和及时的干预。

挑战/限制

  • 测试设备成本高

肺功能检测设备价格高昂,限制了小型医疗机构的使用,并阻碍了某些地区的普及,从而阻碍了市场的增长。购买和维护复杂的肺功能检测设备需要大量投资,这对医疗机构(尤其是发展中地区的医疗机构)构成了财务挑战。这一经济障碍限制了肺功能检测技术的广泛采用和使用,影响了整个市场的增长和可及性。解决这些成本挑战对于提高全球肺功能检测的覆盖面和影响力至关重要。

  • 测试结果缺乏标准化和差异性

缺乏统一标准导致设备规格和测试协议存在差异,从而影响不同设备之间测试结果的一致性和可比性。这种差异性使将 PFT 设备与电子健康记录 (EHR) 系统集成变得复杂,使得无缝数据交换和全面的患者记录更加难以实现。如果没有标准化协议,确保来自各种 PFT 设备的数据能够准确高效地集成到 EHR 系统中仍然是一项复杂的任务。

最新动态

  • 2024 年 4 月,Clario 收购 ArtiQ,通过整合先进的 AI 功能增强了其呼吸解决方案产品组合。这一战略举措将 Clario 的专业知识与 ArtiQ 的创新技术相结合,以提高测试质量并加速临床试验中的数据处理。此次收购与 Inofab Health 一起巩固了 Clario 在呼吸护理领域的领导地位,并拓宽了其 AI 驱动的临床解决方案
  • 2023 年 9 月,PulmOne 在中国推出了 MiniBox+,并通过我们的经销商 HTDK 在 2023 年中华医学会胸科学分会 (CTS) 年会上向肺病专家展示。此次介绍受到了与会者的热烈欢迎。查看此次活动的精彩视频集锦
  • 2023 年 5 月,Geratherm Medical AG 被图林根州开发公司 (LEG) 评为“隐形冠军”。这一认可凸显了该公司在医疗技术领域的重要作用及其全球市场地位。董事会成员 Christian Frick 对这一荣誉表示感谢,并指出该公司在医疗诊断、肺功能测量、中风预防和孵化器系统方面的创新,为其未来发展奠定了良好的基础
  • 2023 年 5 月,呼吸诊断领域的领导者 Vitalograph 在 ATS 国际会议上推出了 Vitalograph tremoflo C-100 示波器,扩大了其产品组合。这款创新设备由该公司与 Thorasys 合作开发,可通过简单的潮气呼吸检测小气道损伤,从而增强哮喘和 COPD 的诊断能力。tremoflo C-100 与 Vitalograph Spirotrac 平台集成,可全面了解呼吸健康情况,并支持在各种环境下进行准确、便携的测试
  • 2023 年 4 月,Ingmar Medical 推出了 RespiSim 软件版本 4.3,这是一项重要改进,包括改进了场景导入/导出、减少了模拟延迟并增强了平台稳定性。这些更新显著提高了可用性和性能,使其成为呼吸治疗教育和培训的重要工具
  • 2022 年 9 月,IngMar Medical 推出了 RespiSim eLearning,这是一个基于订阅的平台,提供价格合理、逼真的通气培训。这款新产品配备了虚拟呼吸机和一套克利夫兰诊所课程,支持混合和远程教育,培养了一个致力于改善患者治疗效果的教育者社区

亚太肺功能测试市场范围

亚太地区肺功能测试市场根据类型、患者类型、应用和最终用户分为四个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

类型

  • 硬件
  • 软件
  • 服务

根据服务,亚太肺功能测试市场分为硬件、软件和服务。

患者类型

  • 成人
  • 老年
  • 儿科

根据患者类型,亚太肺功能测试市场分为成人、老年人和儿童。

应用

  • 阻塞性肺病
  • 限制性肺病

根据应用,亚太肺功能测试市场分为阻塞性肺病和限制性肺病。

最终用户

  • 医院
  • 专科诊所
  • 诊断实验室
  • 家庭护理设置
  • 其他的

根据最终用户,亚太肺功能测试市场分为医院、专科诊所、诊断实验室、家庭护理环境等。

亚太肺功能测试市场区域分析/见解

亚太肺功能测试市场根据类型、患者类型、应用和最终用户分为四个显著的部分。

本市场报告涵盖的国家包括中国、印度、韩国、日本、泰国、澳大利亚、新加坡、印度尼西亚、台湾、新西兰、越南、马来西亚、菲律宾和亚太地区其他地区。

由于技术的快速进步以及政府的举措和报销政策,日本有望在亚太地区市场占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了大型服务公司的存在和可用性以及它们因来自本地和国内参与者的激烈或稀少的竞争而面临的挑战以及销售渠道的影响。

竞争格局和亚太肺功能测试市场份额分析

亚太地区肺功能测试市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用主导地位以及产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。

该市场的主要市场参与者包括 VYAIRE MEDICAL, INC.、Teleflex Incorporated、CAIRE, Inc.、COSMED srl、Schiller AG、Ganshorn Medizin Electronic GmbH、KoKo PFT、ECO MEDICS、Clarity Medical、Data Sciences International、JK Medical System Pvt. Ltd、Scireq、MEDLINE、Recorders and Medicare Systems、VITALOGRAPH、CHEST MI, Inc.、CONTEC MEDICAL SYSTEMS CO., LTD 和 FUKUDA SANGYO CO., LTD. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

5 REGULATORY FRAMEWORK

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES

6.1.2 EARLY DETECTION OF RESPIRATORY DISEASES

6.1.3 GROWING GERIATRIC POPULATION

6.1.4 INCREASING PRODUCT LAUNCHES AND EMERGENCE OF HOME TESTING DEVICES

6.2 RESTRAINTS

6.2.1 HIGH COST OF TESTING EQUIPMENT

6.2.2 TECHNOLOGICAL LIMITATION OF TESTING DEVICES

6.3 OPPORTUNITIES

6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS

6.3.2 RISING STRATEGIC INITIATIVES

6.3.3 GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES

6.3.4 PRODUCT DEVELOPMENT FOR AT-HOME TESTING

6.4 CHALLENGES

6.4.1 LACK OF STANDARDIZATION AND VARIABILITY IN TEST RESULTS

6.4.2 LACK OF SKILLED PROFESSIONALS

7 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE

7.1 OVERVIEW

7.2 HARDWARE

7.2.1 PFT DEVICES

7.2.2 PFT ACCESSORIES & CONSUMABLES

7.2.2.1 Spirometry

7.2.2.2 Lung Volume in Unit/ Plethysmography Test

7.2.2.3 Gas Exchange Testing

7.2.2.4 Cardiopulmonary Exercise Test (CPET)

7.2.2.5 Pulse Oximetry Test

7.2.2.6 Diffusion Capacity Test

7.2.2.7 Maximal Voluntary Ventilation

7.2.2.8 Oxygen Titration Test

7.2.2.9 Respiratory Muscle Function

7.2.2.10 Bronchial Provocation Test

7.2.2.11 High Altitude Simulation Testing

7.2.3 OTHERS

7.2.3.1 3.2. Direct Tender

7.2.3.2 3.2. Retail Sales

7.2.4 OTHERS

7.3 SOFTWARE

7.4 SERVICES

8 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE

8.1 OVERVIEW

8.2 ADULT

8.2.1 MALE

8.2.2 FEMALE

8.3 GERIATRIC

8.3.1 MALE

8.3.2 FEMALE

8.4 PEDIATRIC

8.4.1 MALE

8.4.2 FEMALE

9 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 OBSTRUCTIVE LUNG DISEASE

9.2.1 ASTHMA

9.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

9.2.3 BRONCHIECTASIS

9.2.4 CYSTIC FIBROSIS

9.3 RESTRICTIVE LUNG DISEASE

9.3.1 LUNG CANCER

9.3.2 INTERSTITIAL LUNG DISEASE

9.3.3 AMYOTROPHIC LATERAL SCLEROSIS (ALS)

9.3.4 SCOLIOSIS

9.3.5 SARCOIDOSIS

9.3.6 MUSCULAR DYSTROPHY

10 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 PUBLIC

10.2.2 PRIVATE

10.3 SPECIALTY CLINICS

10.4 DIAGNOSTICS LABORATORIES

10.5 HOME CARE SETTINGS

10.6 OTHERS

11 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY REGION

11.1 ASIA-PACIFIC

11.1.1 JAPAN

11.1.2 CHINA

11.1.3 SOUTH KOREA

11.1.4 INDIA

11.1.5 AUSTRALIA

11.1.6 SINGAPORE

11.1.7 TAIWAN

11.1.8 THAILAND

11.1.9 MALAYSIA

11.1.10 NEW ZEALAND

11.1.11 INDONESIA

11.1.12 VIETNAM

11.1.13 PHILIPPINES

11.1.14 REST OF ASIA-PACIFIC

12 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 VYAIRE MEDICAL, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 COMPANY SHARE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.2 TELEFLEX INCORPORATED

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO 225

14.2.5 RECENT DEVELOPMENT 225

14.3 CAIRE INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 COMPANY SHARE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENTS

14.4 COSMED SRL

14.4.1 COMPANY SNAPSHOT

14.4.2 COMPANY SHARE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 SCHILLER AG

14.5.1 COMPANY SNAPSHOT

14.5.2 COMPANY SHARE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENTS

14.6 CHEST M.I., INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 CLARITY MEDICAL

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENT

14.8 CONTEC MEDICAL SYSTEMS CO., LTD

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 DATA SCIENCES INTERNATIONAL.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 ECO MEDICS

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 FUKUDA SANGYO CO., LTD.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 GANSHORN MEDIZIN ELECTRONIC GMBH

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 GERATHERM MEDICAL AG

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENT

14.14 INGMAR MEDICAL

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 INOFAB HEALTH (A CLARIO COMPANY)

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 JK MEDICAL SYSTEMS PVT LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 KOKO, PFT

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 MEC

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 MEDICAL EQUIPMENT EUROPE GMBH

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 MEDLINE

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 MORGAN SCIENTIFIC

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENTS

14.22 NDD MEDICAL TECHNOLOGIES

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENTS

14.23 PULMONE ADVANCED MEDICAL DEVICES

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENT

14.24 RECORDERS & MEDICARE SYSTEMS PRIVATE LIMITED

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENT

14.25 SCIREQ

14.25.1 COMPANY SNAPSHOT

14.25.2 PRODUCT PORTFOLIO

14.25.3 RECENT DEVELOPMENT

14.26 SIBEL, S.A.U

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENT

14.27 VITALOGRAPH

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

表格列表

TABLE 1 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 2 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 3 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 4 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 5 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 6 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 7 ASIA-PACIFIC PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 8 ASIA-PACIFIC PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 9 ASIA-PACIFIC MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 10 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 11 ASIA-PACIFIC NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 12 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 13 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 15 ASIA-PACIFIC SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 ASIA-PACIFIC SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 18 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 19 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 20 ASIA-PACIFIC GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 ASIA-PACIFIC GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 22 ASIA-PACIFIC PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 23 ASIA-PACIFIC PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 24 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 25 ASIA-PACIFIC OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 26 ASIA-PACIFIC OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 27 ASIA-PACIFIC RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 ASIA-PACIFIC RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 29 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 30 ASIA-PACIFIC HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 31 ASIA-PACIFIC HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 ASIA-PACIFIC SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 33 ASIA-PACIFIC DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 34 ASIA-PACIFIC HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 35 ASIA-PACIFIC OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 36 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 37 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 38 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 40 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 41 ASIA-PACIFIC PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 42 ASIA-PACIFIC MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 43 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 44 ASIA-PACIFIC NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 45 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 46 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 47 ASIA-PACIFIC RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 48 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 49 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 50 ASIA-PACIFIC GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 51 ASIA-PACIFIC PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 52 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 53 ASIA-PACIFIC OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 54 ASIA-PACIFIC RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 55 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 56 ASIA-PACIFIC HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 JAPAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 58 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 61 JAPAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 JAPAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 63 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 64 JAPAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 65 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 66 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 67 JAPAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 68 JAPAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 70 JAPAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 71 JAPAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 72 JAPAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 73 JAPAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 74 JAPAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 75 JAPAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 76 JAPAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 77 CHINA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 78 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 80 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 81 CHINA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 82 CHINA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 84 CHINA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 85 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 87 CHINA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 88 CHINA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 89 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 90 CHINA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 91 CHINA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 92 CHINA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 93 CHINA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 94 CHINA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 95 CHINA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 96 CHINA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 97 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 100 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 101 SOUTH KOREA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 102 SOUTH KOREA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 103 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 104 SOUTH KOREA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 105 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 106 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 107 SOUTH KOREA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 108 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 109 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 110 SOUTH KOREA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 111 SOUTH KOREA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 112 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 113 SOUTH KOREA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 114 SOUTH KOREA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 115 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 116 SOUTH KOREA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 117 INDIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 118 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 119 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 120 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 121 INDIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 122 INDIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 123 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 124 INDIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 125 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 126 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 127 INDIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 128 INDIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 129 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 130 INDIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 131 INDIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 132 INDIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 133 INDIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 134 INDIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 135 INDIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 136 INDIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 137 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 138 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 139 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 140 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 141 AUSTRALIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 142 AUSTRALIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 143 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 144 AUSTRALIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 145 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 146 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 147 AUSTRALIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 148 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 149 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 150 USTRALIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 151 AUSTRALIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 152 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 153 AUSTRALIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 154 AUSTRALIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 155 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 156 AUSTRALIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 157 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 158 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 159 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 160 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 161 SINGAPORE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 162 SINGAPORE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 163 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 164 SINGAPORE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 165 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 166 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 167 SINGAPORE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 168 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 169 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 170 SINGAPORE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 171 SINGAPORE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 172 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 173 SINGAPORE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 174 SINGAPORE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 175 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 176 SINGAPORE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 177 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 178 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 179 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 180 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 181 TAIWAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 182 TAIWAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 183 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 184 TAIWAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 185 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 186 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 187 TAIWAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 188 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 189 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 190 TAIWAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 191 TAIWAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 192 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 193 TAIWAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 194 TAIWAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 195 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 196 TAIWAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 197 THAILAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 198 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 199 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 200 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 201 THAILAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 202 THAILAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 203 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 204 THAILAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 205 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 206 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 207 THAILAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 208 THAILAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 209 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 210 THAILAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 211 THAILAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 212 THAILAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 213 THAILAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 214 THAILAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 215 THAILAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 216 THAILAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 217 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 218 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 219 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 220 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 221 MALAYSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 222 MALAYSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 223 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 224 MALAYSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 225 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 226 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 227 MALAYSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 228 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 229 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 230 MALAYSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 231 MALAYSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 232 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 233 MALAYSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 234 MALAYSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 235 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 236 MALAYSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 237 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 238 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 239 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 240 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 241 NEW ZEALAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 242 NEW ZEALAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 243 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 244 NEW ZEALAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 245 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 246 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 247 NEW ZEALAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 248 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 249 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 250 NEW ZEALAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 251 NEW ZEALAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 252 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 253 NEW ZEALAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 254 NEW ZEALAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 255 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 256 NEW ZEALAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 257 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 258 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 259 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 260 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 261 INDONESIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 262 INDONESIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 263 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 264 INDONESIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 265 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 266 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 267 INDONESIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 268 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 269 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 270 INDONESIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 271 INDONESIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 272 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 273 INDONESIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 274 INDONESIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 275 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 276 INDONESIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 277 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 278 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 279 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 280 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 281 VIETNAM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 282 VIETNAM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 283 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 284 VIETNAM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 285 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 286 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 287 VIETNAM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 288 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 289 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 290 VIETNAM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 291 VIETNAM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 292 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 293 VIETNAM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 294 VIETNAM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 295 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 296 VIETNAM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 297 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 298 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 299 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 300 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 301 PHILIPPINES PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 302 PHILIPPINES MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 303 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 304 PHILIPPINES NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 305 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 306 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 307 PHILIPPINES RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 308 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 309 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 310 PHILIPPINES GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 311 PHILIPPINES PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 312 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 313 PHILIPPINES OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 314 PHILIPPINES RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 315 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 316 PHILIPPINES HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 317 REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

图片列表

FIGURE 1 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 11 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031

FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031

FIGURE 16 DROC ANALYSIS

FIGURE 17 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023

FIGURE 18 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 19 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 20 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023

FIGURE 22 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)

FIGURE 23 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)

FIGURE 24 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023

FIGURE 26 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)

FIGURE 27 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 28 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY END USER 2023

FIGURE 30 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 31 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)

FIGURE 32 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE

FIGURE 33 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)

FIGURE 34 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Asia-Pacific Pulmonary Function Testing Market, By Type (Hardware, Services, and Software), Patient Type (Pediatric, Adult, and Geriatric), Application (Obstructive Lung Disease and Restrictive Lung Disease), End User (Hospital, Specialty Clinics, Diagnostics Laboratories, Home Care Settings, and Others) - Industry Trends and Forecast to 2031. .
The Asia Pacific Pulmonary Function Testing Market size was valued at USD 721.36 USD Million in 2023.
The Asia Pacific Pulmonary Function Testing Market is projected to grow at a CAGR of 7.7% during the forecast period of 2024 to 2031.
The market report covers data from the China, India, South Korea, Japan, Thailand, Australia, Singapore, Indonesia, Taiwan, New Zealand, Vietnam,  Malaysia, Philippines, and rest of Asia-Pacific.